FREMONT, Calif., Feb. 23, 2021 /PRNewswire/ -- The premium market
intelligence report published by BIS Research on the title Global
Single-Cell Multi-Omics Market highlights that the market is
projected to reach $3.18 billion by
2025. The study also highlights that the market is set to witness a
CAGR of 21.16% during the period between 2020 and 2025. The
growth is aided by factors including increasing utilization of
single-cell RNA sequencing for various cancer research.
The single-cell multi-omics approach enables integrating
different molecules and analyzing different types of molecules from
a same cell. This helps in accessing multi-faceted information and
insights on the characteristics of molecular layers of several
individual cells. The information derived is further beneficial in
diagnosing and modifying the drugs being developed. Through the
advances in single-cell analysis assays, information on the
genotypic and phenotypic traits could be revealed along with the
regulatory mechanism of the cell at a single-cell resolution.
Browse 14 Market Data Tables and 167 Figures spread through
228 Pages and in-depth TOC on "Global Single-Cell Multi-Omics
Market"
The comprehensive study covers the following:
- Market numbers on micro-segments that are influencing the
market
- More than 300 products present in the market
- Market share analysis for more than 15 companies
- End-user preference data for over 20 end users
- Detailed global and regional market share analysis including
the scrutiny of more than 15 countries
- Study of data of more than 30 companies
Who Should Buy This Report?
- Manufacturers of sequencing instruments, kits, assays, and
consumables
- Manufacturers of imaging instruments, kits, assays, and
consumables
- Companies involved in drug manufacturing and diagnostics
development
- Companies in the services market such as contract research
organization
- Companies involved in developing bioinformatics tools for
single-cell data analysis, visualization, sharing, and storage
To gain a holistic view of the market, data from different
segments of the market has been analyzed minutely. These segments
include end user and market share analysis, types of products
offered, type of omics, sample type, application, and region. Each
of these segments is further categorized into sub-segments and
micro-segments to compile an in-depth study.
View the Report from BIS Research:
https://bisresearch.com/industry-report/global-single-cell-multi-omics-market.html
The premium market intelligence by BIS Research additionally
throws a spotlight on the opportunities existing in the market,
including the high scope for adoption of genomic-based medicine in
emerging nations, increased use of single-cell technology solutions
for the development of therapeutics drugs and comprehensive
treatment plan, and requirement for the development of advanced
solutions based on single-cell technology, among others.
The end user and pricing analysis of the global market includes
data analysis on the satisfaction level of different instruments
(by brand), pricing analysis of preferred instruments, accessories
& components, and consumables. The study is majorly centered on
the sub-segments and micro-segments of the different product
markets, such as consumables and instruments. The consumables are
further categorized into kits and reagents.
To emphasize the dominance of the consumable segment over the
instruments segment under the product category of single-cell
multi-omics market in 2020 and 2025, Nitish Kumar Singh, Principal Analyst –
BIS Research, states, "The reason for market growth can be
attributed to the large-scale research and development and recent
advancement in sequencing technologies aiding researchers to
unravel translational and transcription events at a single-cell
resolution, attracting many molecular diagnostics and pharma giants
to expand their portfolios in this sector ."
Request for a Sample:
https://bisresearch.com/requestsample?id=1061&type=download
Key insights are drawn from in-depth interviews with the key
opinion leaders of more than 15 leading companies, market
participants, and vendors. The key players profiled in the report
include NanoString Technologies, Inc., RareCyte, Inc., Fluidigm
Corporation, 10x Genomics, Inc., Becton, Dickinson and Company,
Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories,
Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley
Lights, Takara Bio, Inc., Dolomite
Bio, and Bio-Techne Corporation. The report also contains company
profiles of five emerging players, namely Proteona, BioTuring Inc.,
Scipio Biosciences SAS, Parse Biosciences, Inc., and Shilps
Sciences.
The study also offers strategic recommendations that can help
organizations in tracking various products, trends, and
technologies that are changing the dynamics of the market. The
recommendations by BIS Research also offer bespoke research
services to help organizations meet their objectives.
For Custom Research, please visit
https://bisresearch.com/our-offerings/custom-research
How can market intelligence on single-cell multi-omics add
value to an organization's decision-making process?
- Aid in product development
- Help in targeting a segment for launching a new product
- Offer detailed information on the future perspective of the
emerging as well as established players
- Offer go-to-market strategies for the different source
type
- Support in diversifying the product portfolio based on risk and
progression of technology (DNA, RNA, and Analyte)
- Help in analyzing technological substitutes and compare the
specification
- Offer tailor-made solutions based on the throughput of
different consumers
- Aid in understanding the technology requirement
- Assist in exploring the newer application
- Support in analyzing the competitors' funding scenario
- Support in understanding the involvement of government health
organizations such as the National Institute of Health (NIH)
- Aid in understanding the new trends in the industry
Insightful Questions Covered to Enable Companies take
Strategic Decisions
- What are the major market drivers, challenges, and
opportunities in the global single-cell multi omics market?
- What is the potential impact of biotechnological advancements
in the diagnostic industry among end users such as researchers,
pathologists, and laboratory technicians?
- What is the current market demand along with future expected
demand for the global single-cell multi-omics market?
- What are the key development strategies that are implemented by
the major players in order to sustain the competitive market?
- How is each segment of the market expected to grow during the
forecast period from 2020 to 2025? Following are the segments:
-
- Product type
- Omics type
- Technique
- Sample type
- Application
- End user
- Region
- Which are the leading players with significant offerings to the
global single-cell multi-omics market?
- What is the expected market dominance for each of these leading
players?
- Which emerging companies are anticipated to be highly
disruptive in the future, and what are their key strategies for
sustainable growth in the global single-cell multi-omics
market?
Related Reports:
Global Molecular Diagnostics Point of Care Market: 2019-2029
Global Molecular Diagnostics Market: 2018-2028
Global Single-Cell-Sequencing Market:
2018-2029
About BIS Research:
BIS Research, a premium market intelligence company offers
in-depth insights and consulting to Fortune 500 companies. We are
established and known for tracking the growth of deep technologies
across key industry verticals and the subsequent challenges and
opportunities associated with deep tech across markets,
applications and products.
With more than 500 clients, over 7000 plus primary interviews
and approximately 200 reports published in a year BIS Research has
set an interesting growth trajectory for itself. We provide market
estimations, emerging high-growth applications, technology
analysis, highly segmented granular country-level market data, and
other important market parameters that come in handy for our
clients during strategic decision-making.
We publish a wide gamut of syndicated market studies across
industry verticals. In addition, bespoke market studies is another
area where BIS Research excels at along with consulting
services.
BIS Healthcare vertical offers intelligence in the healthcare
technology market for Medical Devices, Digital Health, Life
Sciences, Robotics and Imaging, Information Technology, MRD
testing, and other emerging healthcare technologies, covering the
entire industry spectrum. In the past 5 years, BIS Healthcare has
published more than 50 reports under the precision medicine banner.
Additionally, BIS Research has been nominating Top 25 Voices in
precision medicine on its Insight Monk platform for the past two
years successfully.
Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @
https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch
Logo:
https://mma.prnewswire.com/media/495163/BIS_Research_Logo.jpg